[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"heart-murmurs\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:heart-murmurs":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100528044","eko-sensora-detecting-clinically-significant-murmurs-100528044",false,"NCT06155643","EKO SENSORA: Detecting Clinically Significant Murmurs","EkoNM","Inclusion Criteria:\n\n* Chief complaint of chest pain, shortness of breath, difficulty breathing, or syncope\u002Fnear-syncope.\n* Patients with chief complaint of Weakness would be eligible if over the age of 50 and have a history of at least two of hypertension, BMI\\>\u002F= 30, diabetes, hyperlipidemia, atrial fibrillation, heart attack, stroke\u002FTransient ischemic attack, prior cardiac surgery or angiography\n\nExclusion Criteria:\n\n* Contact isolation patients\n* Pediatric patients under the age of 18","ALL","18 Years",{"count":19,"type":20},300,"ESTIMATED","INTERVENTIONAL",[23],"NA","The Eko Artificial Intelligence (AI) has primarily been evaluated in the primary care setting. The digital stethoscope records a phonocardiogram of heart sounds of the patient and uses machine learning artificial intelligence to identify if there are abnormalities present (Eko Health, 2023).\n\nThe Eko SENSORA will be tested in the emergency department. Chest pain, fatigue, shortness of breath and syncope are all symptoms that could indicate a cardiac dysfunction.\n\nThe hypothesis is that this device will allow us increased ability to detect valvular heart disease that is clinically significant.",[26],"Heart Murmurs",[28,29,30,31,32],"eko","heart murmur","ai","machine learning","heart murmur detection","RECRUITING","2025-12-05",{"date":36,"type":37},"2025-12-12","ACTUAL",{"date":39,"type":37},"2023-10-26",{"date":41,"type":20},"2026-07-26",{"name":43,"class":44},"Corewell Health South","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":16,"minAge":4,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":59,"conditions":60,"keywords":62,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":45},"100596336","validate-the-efficacy-and-the-safety-of-the-keikku-electronic-stethoscope-for-its-indication-and-intended-purpose-under-the-intended-conditions-of-use-100596336","NCT07044128","Validate the Efficacy and the Safety of the Keikku Electronic Stethoscope for Its Indication and Intended Purpose, Under the Intended Conditions of Use.","Prospective, Controlled, Open-label Study Evaluating the Keikku Electronic Stethoscope","KCI-1","Inclusion Criteria:\n\n* Pediatric, including newborn (from birth to 1 month of age), or adult (aged 99 or below) individuals.\n* Individuals who are either:\n\n  * presenting for initial, non-urgent outpatient evaluation of a cardiac murmur or for non-urgent cardiac clearance; or\n  * presenting for return, non-urgent outpatient evaluation of a cardiac murmur; or\n  * undergoing initial or recurrent, non-urgent evaluation of a cardiac murmur in inpatient setting; or\n  * undergoing non-urgent cardiac clearance in inpatient setting.\n\nExclusion Criteria:\n\npregnant female individuals",true,"99 Years",{"count":57,"type":20},149,"OBSERVATIONAL","This study is testing a digital stethoscope called the Keikku electronic stethoscope. Doctors use stethoscopes to listen to the heart, and this new device records heart sounds using a smartphone app. The purpose of the study is to check how well this new device works and whether it is safe to use.\n\nThe study will include 149 participants of all ages (from birth to 99 years), who are undergoing routine (non-urgent) heart checks. After giving consent, each participant will have their heart sounds listened to twice: once with the Keikku electronic stethoscope and once with a regular stethoscope. Two different doctors will do the listening, and they won't share information with each other. The doctors will record whether they hear a heart murmur and how clear the sounds were.\n\nThe study will compare the findings from the new device to those from the regular stethoscope. Researchers will also check for any device problems or side effects. The study takes place at a single site in Peru and will take about one day for each participant.\n\nThe goal is to find out if the Keikku electronic stethoscope is accurate and safe for doctors to use in real medical settings.",[26,61],"Wheezing",[63,26,64,65,66,67,68,69,70,71,72,73,74,75],"Stethoscopes","Cardiac Auscultation","Diagnostic Techniques and Procedures","Medical Device Evaluation","Sound Recording and Reproduction","Pediatric Cardiology","Adult Cardiology","Telemedicine","Signal Processing, Computer-Assisted","Electronic Health Records","Clinical Accuracy","Safety Assessment","Prospective Studies","2025-06-23",{"date":78,"type":37},"2025-06-29",{"date":80,"type":20},"2025-07-15",{"date":82,"type":20},"2025-10-15",{"name":84,"class":85},"Lapsi Health Holding B.V.","INDUSTRY"]